This Week in Cannabis News: July 4 – July 10, 2022

This Week in Cannabis News: July 4 – July 10, 2022
L-Theanine Gummies

*This information is not investment advice. This information is for educational purposes only. *
Mid-Week Update: M
Cresco Q1: I
Trulieve Q1: Y
GTI Q1: k
Curaleaf Q1: U
Verano & Ayr Q1: I

Timecodes:
00: 00 – Intro – 00: 40 – Akerna Reports $256M in 7/4 Sales – 1: 10 – MT Sets June Record
1: 52 – New Mexico Sales Total $38M in June – 2: 25 – FL Adds 1,845 Patients
3: 18 – May Sales Decline Slightly But Notice March, July and December Trend?
12: 00 – 7/10 – Other Holiday for Dabbers – 12: 34 – Senators Pressuring Biden Again
13: 49 – Same Story From Bloomberg – 13: 59 – Leafly on Same Idea.. Come on Man!
14: 29 – Height on SAFE Banking – 14: 50 – Will Big Tobacco Invest in Canna Growth?
15: 53 – DC Overrides Rider Blocking Adult Use By Making Everyone Medical Patient!
16: 20 – NY Office of Canna Management Finally Cracking Down on Illicit Vendors
17: 00 – NE On Pace to Qualify for 2022 Ballot – 17: 20 – As Will AR Activists Apparently
17: 45 – Columbia Care Shareholders Approve Acquisition with 98.5% of Votes FOR
18: 20 – Trulieve Files S-3, Better to Have Option Than Not – 19: 02 – Verano & Yale Collab?
19: 45 – NIH Studying Cannabis? How convenient for Gov, how about de-scheduling?
20: 14 – TheStreet.com Article – Expecting Canna Sales Going Up in Coming Recession?
20: 36 – Study Shows Flower is King in US & CA
21: 00 – US Leaders Need to Fix Cannabis Laws Before Demanding Griner’s Release

Sources:
1

a

/

f

/

/

/

2

s

2

1

7

4

9

/

o

1

2

/

7

n

/

/

This Week in Cannabis provides a weekly recap on the Cannabis industry, for retail investors. It focuses on the potential opportunities in North America and how they can be capitalized before Cannabis goes global.

Disclaimer
This is not an investment advice. This is educational entertainment for investors to learn more about the US Cannabis Industry. Invest at your risk.

Brain & Body Power Free Trial

You May Also Like

Leave a Reply